From: Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors
Clinicopathological feature | Â |
---|---|
Patients, n | 85 |
Gender, n (%) | Â |
   Male | 52 (61.2) |
   Female | 33 (38.8) |
Age, yr, median (range) | 61 (36–86) |
Histologic subtype, n (%) | Â |
   Clear cell RCC | 52 (61.2) |
   Papillary RCC | 13 (15.2) |
   Chromophobe RCC | 10 (11.8) |
   Oncocytoma | 10 (11.8) |
Pathologic stage*, n (%) | Â |
   T1 | 42 (56) |
   T2 | 15 (20) |
   T3 | 16 (21.4) |
   T4 | 2 (2.6) |
Furhman grade, n (%) | Â |
   1 | 2 (2.7) |
   2 | 24 (32.0) |
   3 | 36 (48.0) |
   4 | 13 (17.3) |